Cytokinetics: Q1 Earnings Snapshot
By Ap News
Published - May 08, 2024, 04:09 PM ET
Last Updated - May 27, 2024, 01:00 AM EDT
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $135.6 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.33.
The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.
The biopharmaceutical company posted revenue of $835,000 in the period, which also did not meet Street forecasts. Seven analysts surveyed by Zacks expected $1.1 million.
